Breast Cancer Screening Is Evolving: Why Risk-Based Prevention Matters
- Saneka Chakravarty, MD, FACC
- Dec 13, 2025
- 3 min read
For decades, breast cancer screening has followed a simple rule: start mammograms at a certain age and repeat them on a fixed schedule. While this approach has saved lives, it was built on older science, before we fully understood how different breast cancers are, and how widely risk varies from person to person.
Today, we know something important: breast cancer risk is not the same for everyone. And prevention works best when it’s personal.
A large U.S. study called WISDOM (Women Informed to Screen Depending on Measures of Risk) provides the strongest evidence yet that a risk-based approach to breast cancer screening is safe, effective, and preferred by women.
At Preventiononly, this is exactly the kind of shift we believe in, moving from one-size-fits-all care to precision prevention.
Why Age-Based Screening Falls Short
Traditional screening guidelines rely heavily on age. But age alone doesn’t capture:
Breast density
Family history limitations
Genetic risk beyond BRCA
Lifestyle and reproductive factors
Differences in tumor biology
As a result:
Many low-risk women undergo frequent screening and unnecessary biopsies
Many high-risk cancers appear between routine screens
Nearly 75% of breast biopsies in the U.S. are benign
Costs and anxiety continue to rise: without proportional benefit
What the WISDOM Study Did Differently
The WISDOM trial enrolled over 46,000 women across the U.S. and compared:
Standard annual screening starting at age 40
vs.
Risk-based screening, tailored using:
Clinical risk factors
Breast density
Genetic testing (including polygenic risk scores and high-risk genes)
Women were grouped into four risk categories, lowest, average, elevated, and highest and screening recommendations were adjusted accordingly.
The Key Finding: Risk-Based Screening Is Safe
The most important question was safety.
Did screening less often for low-risk women lead to more advanced cancers?
The answer: No.
Rates of advanced breast cancer (stage ≥IIB) were no higher in the risk-based group
Risk-based screening met strict safety thresholds
There was no increase in late-stage diagnoses
This means personalized screening can safely replace blanket annual screening, without putting women at greater risk.
Why Risk-Based Screening Improves Prevention
1. High-Risk Women Get More Protection
Women at highest risk received:
Earlier screening
More frequent imaging
MRI when appropriate
Importantly, many high-risk women had no family history, meaning they would have been missed by traditional approaches.
2. Low-Risk Women Avoid Unnecessary Harm
Women at low risk:
Safely screened less often
Had fewer mammograms
Avoided unnecessary procedures and anxiety
This matters because screening is not harmless: false positives, biopsies, and overdiagnosis carry real physical and emotional costs.
3. Genetics Makes Prevention Actionable
Three-quarters of participants completed at-home genetic testing, proving that population-level genetic risk assessment is feasible.
When women understood their risk:
Use of risk-reducing therapies doubled in the highest-risk group
Prevention moved from awareness to action
What This Means for the Future of Screening
The WISDOM trial confirms a core principle of prevention:
The right care, for the right person, at the right time.
Risk-based screening:
Aligns resources where they matter most
Reduces unnecessary interventions
Supports value-based care
Empowers informed, shared decision-making
Future versions of WISDOM will go even further: using AI imaging, ancestry-specific genetics, and subtype-specific risk prediction.
How Preventiononly Fits In
At Preventiononly, we believe:
Everyone has something to improve
Prevention should be personal, proactive, and data-driven
Health decisions should be guided by your risk, not averages
Risk-based screening reflects the future of healthcare we’re building:
Smarter prevention
Earlier action
Less harm
Better outcomes
The Bottom Line
Breast cancer screening doesn’t need to be one-size-fits-all.
The science is clear:
Personalized, risk-based prevention is safe, scalable, and preferred.
Prevention works best when it’s personal, and that’s where healthcare is headed.
FAQs
Is risk-based screening widely available today?
Not yet. Most guidelines are still age-based, but studies like WISDOM are shaping future recommendations.
Does this mean mammograms aren’t important?
No. Mammograms remain essential, but how often and when to start should depend on individual risk.
Is genetic testing only for people with family history?
No. Many high-risk women identified in WISDOM had no known family history.
Comments